Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon
- PMID: 16100146
- DOI: 10.1378/chest.128.2.618
Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon
Abstract
Study objectives: In obese patients, obstructive sleep apnea syndrome (OSAS) is attributed to a reduction in pharyngeal cross-sectional area due to peripharyngeal fat deposition. The effect of weight loss on the size of the upper airways of obese subjects is still unknown. We analyzed the pharyngeal cross-sectional area before and after weight loss in morbidly obese patients with OSAS.
Design, setting, and subjects: A group of 17 middle-aged, morbidly obese men was evaluated by anthropometry and cardiorespiratory sleep studies before and after weight loss obtained by insertion of an intragastric balloon. The pharyngeal cross-sectional area was measured by acoustic pharyngometry.
Results: The mean (+/- SD) body mass index was 55.8 +/- 9.9 kg/m2 at baseline and 48.6 +/- 11.2 kg/m2 at the time of balloon removal (6 months after insertion) [p < 0.001]. At baseline, patients had visceral obesity, large necks, and severe OSAS. Weight loss was associated with a significant mean reduction of waist circumference (156.4 +/- 17.6 vs 136.7 +/- 18.4 cm, respectively; p < 0.001), sagittal abdominal diameter (37.8 +/- 3.0 vs 32.3 +/- 4.0 cm, respectively; p < 0.001), and neck circumference (51.1 +/- 3.7 vs 47.9 +/- 4.3 cm, respectively; p < 0.001). Moreover, weight loss induced a nearly complete resolution of OSAS (apnea-hypopnea index, 52.1 +/- 14.9 vs 14.0 +/- 12.4 events/h, respectively; p < 0.001). At baseline, obese patients had significantly lower pharyngeal cross-sectional areas compared to a group of 20 nonobese male control subjects, both in the upright and supine position, at different levels of the pharynx. In obese patients, the weight loss induced by the positioning of the intragastric balloon was associated with an increase in the size of the upper airway passage. After weight loss, both the mean pharyngeal cross-sectional area and the area at glottis level were still lower in obese subjects than in nonobese subjects; however, the pharyngeal cross-sectional area at the oropharyngeal junction was similar in the two groups.
Conclusions: Morbidly obese men with OSAS have a reduced pharyngeal cross-sectional area. A weight reduction of about 15% of baseline body weight may substantially increase the pharyngeal cross-sectional area and substantially improve the severity of OSAS in morbidly obese subjects with sleep apnea.
Comment in
-
Bariatric surgery for obstructive sleep apnea.Chest. 2005 Aug;128(2):485-7. doi: 10.1378/chest.128.2.485. Chest. 2005. PMID: 16100128 Review. No abstract available.
Similar articles
-
The upper airway and obstructive sleep apnea in morbidly obese women.Sleep. 2004 Mar 15;27(2):352; author reply 353. doi: 10.1093/sleep/27.2.352. Sleep. 2004. PMID: 15124735
-
Relationship between the upper airway and obstructive sleep apnea-hypopnea syndrome in morbidly obese women.Obes Surg. 2007 May;17(5):689-97. doi: 10.1007/s11695-007-9120-4. Obes Surg. 2007. PMID: 17658032
-
Quantitative assessment of the pharyngeal airway by dynamic magnetic resonance imaging in obstructive sleep apnea syndrome.Ann Otol Rhinol Laryngol. 2001 Feb;110(2):183-9. doi: 10.1177/000348940111000215. Ann Otol Rhinol Laryngol. 2001. PMID: 11219527
-
Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway.Respirology. 2012 Jan;17(1):32-42. doi: 10.1111/j.1440-1843.2011.02093.x. Respirology. 2012. PMID: 22023094 Review.
-
Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery.Obes Surg. 2007 Jan;17(1):95-9. doi: 10.1007/s11695-007-9012-7. Obes Surg. 2007. PMID: 17355775 Review.
Cited by
-
Safety of the Ullorex oral intragastric balloon for the treatment of obesity.J Diabetes Sci Technol. 2007 Jul;1(4):574-81. doi: 10.1177/193229680700100416. J Diabetes Sci Technol. 2007. PMID: 19885121 Free PMC article.
-
Does surgically induced weight loss improve daytime sleepiness?Obes Surg. 2011 Oct;21(10):1535-45. doi: 10.1007/s11695-010-0213-0. Obes Surg. 2011. PMID: 20596790
-
Is obesity a prognostic factor for acute myeloid leukemia outcome?Ann Hematol. 2012 Mar;91(3):359-65. doi: 10.1007/s00277-011-1319-8. Epub 2011 Sep 21. Ann Hematol. 2012. PMID: 21935651 Free PMC article.
-
Weight loss and brown adipose tissue reduction in rat model of sleep apnea.Lipids Health Dis. 2008 Jul 31;7:26. doi: 10.1186/1476-511X-7-26. Lipids Health Dis. 2008. PMID: 18671859 Free PMC article.
-
Weight Loss and Sleep, Current Evidence in Animal Models and Humans.Nutrients. 2023 Aug 3;15(15):3431. doi: 10.3390/nu15153431. Nutrients. 2023. PMID: 37571368 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical